Eversense Pioneers

Be inspired by the stories of Eversense Pioneers

Eversense Pioneers—early users of Eversense whose lives have been so positively impacted by the 90-day technology, that they want to share their experience with others.

MEET MATT

Techy, super dad and gym rat— hear how Eversense helps Matt be engaged and focused, with no worries that his sensor will be knocked off, no matter what life throws at him.

MEET DIANNE

Dianne is on the road a lot between Florida and Alabama. She and her husband are both relieved that she has Eversense to keep her in a safe range, especially when she’s alone.

MEET ROBERT

Eversense's on-body vibe alert helps Robert stay on top of his levels, even when working in a noisy and chaotic airport environment, where he can’t always hear audio alerts.

MEET YVONNE

Medical receptionist, fitness instructor, and member of a band, Yvonne never stops and neither does her Eversense CGM system, which monitors her blood sugar continuously for 90 days.

The individuals in these videos have been sponsored by Senseonics to appear in the videos. The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider. A Health Care Provider must be consulted and the device user manual reviewed in full before use.

Individual results may vary, testimonials are not claimed to represent typical results. All testimonials are not intended to represent or guarantee that anyone will achieve the same or similar results.

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.